Adenosine Deaminase (ADA) Test
🧪 Adenosine Deaminase (ADA) Test: Purpose, Method, Reference Range, and Clinical Interpretation
The Adenosine Deaminase (ADA) test is a key biomarker that reflects T-lymphocyte activation. It plays an especially crucial role in evaluating tuberculous pleurisy, where ADA levels in pleural fluid provide important diagnostic support. Compared with serum ADA, ADA levels in body fluids—particularly pleural fluid—have significantly greater clinical relevance.
1. 📌 Purpose of ADA Testing
1) Diagnostic support for tuberculous pleurisy
- ADA rises when cell-mediated immunity is activated.
- T-lymphocyte activation is prominent in granulomatous chronic inflammation, such as tuberculosis.
- Pleural fluid ADA is one of the most reliable markers for differentiating tuberculous pleural effusion.
2) Evaluation of lymphocyte-mediated immune activity
- Helps assess states of hyperactive or dysregulated immunity.
- May assist in evaluating lymphocytosis, lymphoma, or immune system disorders.
3) Differential diagnosis of inflammatory effusions
- Useful in distinguishing tuberculous vs malignant vs bacterial pleural effusion.
- May also support diagnosis in ascites and CSF, although interpretation must be cautious.
2. 🧪 Testing Method (Enzymatic Colorimetric Assay)
ADA is typically measured using an enzymatic, colorimetric spectrophotometric method.
1) Principle
- ADA catalyzes:
Adenosine → Inosine + NH₃ - Produced ammonia or secondary reaction products are quantified via spectrophotometry.
- Results reported as U/L.
2) Specimen Types
- Pleural fluid → highest diagnostic utility
- Ascites, CSF, serum → possible but with lower specificity
3) Sample preparation
- Centrifugation to remove debris
- Hemolysis or lipid interference may affect results
- Automated analyzers often use colorimetric kinetic assays
3. 📏 Reference Ranges (Typical Values)
| Specimen | Reference Range |
|---|---|
| Serum | 0–15 U/L |
| Pleural fluid | >40 U/L suggests tuberculous pleurisy |
| Ascites | >33–40 U/L may indicate tuberculous peritonitis |
| CSF | >5 U/L suggests possible tuberculous meningitis |
Note: Reference values vary by laboratory and instrumentation.
4. 🔬 Clinical Significance of ADA
🔺 When ADA is Increased
1) Tuberculous pleurisy (most important indication)
- Lymphocyte-dominant effusion
- High protein
- ADA > 40 U/L shows high sensitivity and specificity
2) Other lymphocyte-mediated inflammation
- Tuberculous peritonitis, meningitis
- Lymphoma
- Rheumatoid pleuritis
- Some hematologic malignancies
3) Immune activation / infection
- Certain parasitic infections
- HIV-related immune activation
- Some bacterial pleuritis
🔻 When ADA is Decreased
- Immunosuppression
- Long-term corticosteroid therapy
- Elderly patients
- T-cell functional impairment
Low ADA does not rule out tuberculosis.
5. 📚 Important Notes for Interpretation
✔ ADA alone cannot confirm tuberculosis
Always interpret with:
- Microbiology (culture, PCR)
- Cytology
- Imaging
- Complete clinical context
✔ Combine with pleural fluid characteristics
- Lymphocyte-dominant + ADA high → strong TB probability
- Neutrophil-dominant + ADA high → bacterial pleuritis possible
✔ Malignancy and lymphoma can also elevate ADA
Clinical history and imaging are essential.
✔ Serum ADA has limited diagnostic value
Pleural fluid ADA is far superior.
✔ Pre-analytical errors matter
- Hemolysis
- Cellular debris
- Inadequate centrifugation
6. 🩺 Diseases Associated With ADA Elevation
| Condition | ADA Elevation | Interpretation |
|---|---|---|
| Tuberculous pleurisy | ⭐ Marked rise | Greatest diagnostic value with lymphocytosis |
| Tuberculous peritonitis/meningitis | High | Useful in CSF/ascites |
| Lymphoma | High | Must differentiate from TB |
| Rheumatoid pleuritis | High | May mimic TB |
| Bacterial pleuritis | Variable | Less specific |
| Malignant pleural effusion | Mild ↑ possible | Not diagnostic |
7. 📚 References
- Light RW. Pleural Diseases, 6th ed.
- Porcel JM. Tuberculous pleural effusion. Lung.
- Henry’s Clinical Diagnosis and Management by Laboratory Methods, 24th ed.
- CLSI C46-A: Body Fluid Analysis Guideline.
- Sharma SK et al. Adenosine deaminase in the diagnosis of tuberculosis. Int J Tuberc Lung Dis.